𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis

✍ Scribed by Ferris, Steven; Karantzoulis, Stella; Somogyi, Monique; Meng, Xiangyi

Book ID
121571095
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
199 KB
Volume
5
Category
Article
ISSN
1758-9193

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of rivastigmine in subjects wit
Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease
✍ A. Burns; R. Spiegel; P. Quarg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## Background Cholinesterase (ChE) inhibitors are primarily used in the treatment of mild to moderate Alzheimer's disease (AD), but may also be effective in more severe disease. ## Objective To evaluate the dual ChE inhibitor, rivastigmine, in more severe dementia. ## Methods We re